Human cathepsin E produced in E. coli
- 1 July 1993
- journal article
- Published by Wiley in FEBS Letters
- Vol. 326 (1-3) , 101-104
- https://doi.org/10.1016/0014-5793(93)81770-z
Abstract
A cDNA for procathepsin E was generated from human gastric adenocarcinoma (AGS) cells, amplified by PCR and inserted into the T7 dependent vector pET 22b for expression in E. coli. Purification of the resultant product was accomplished simply, without the need to resort to column chromatography. The recombinant protein displayed comparable properties to those of its naturally occurring counterpart. The yield of homogeneous active enzyme obtained was ≈ 3 mg per 40 g of cells. This is sufficient to permit crystallisation and structural analysis to begin and a mutagenesis programme to examine structure/activity relationships now to be undertaken.Keywords
This publication has 18 references indexed in Scilit:
- Exploration of subsite binding specificity of human cathepsin D through kinetics and rule‐based molecular modelingProtein Science, 1993
- X-ray analyses of peptide–inhibitor complexes define the structural basis of specificity for human and mouse reninsNature, 1992
- Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin EEuropean Journal of Immunology, 1992
- Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin DBiochemistry, 1992
- Substrate specificity and inhibitors of aspartic proteinasesScandinavian Journal of Clinical and Laboratory Investigation, 1992
- Autocatalytic processing of procathepsin E to cathepsin E and their structural differencesBiochemical and Biophysical Research Communications, 1991
- Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8A˚resolutionJournal of Molecular Biology, 1990
- Structural evidence for two isozymic forms and the carbohydrate attachment site of human gastric cathepsin EBiochemical and Biophysical Research Communications, 1990
- Structure of Recombinant Human Renin, a Target for Cardiovascular-Active Drugs, at 2.5 Å ResolutionScience, 1989
- The Interaction of Aspartic Proteinases With Naturally-Occurring Inhibitors From Actinomycetes and Ascaris LumbricoidesJournal of Enzyme Inhibition, 1985